Trial · NCT02469857
Adverse events142
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
1 to 20 of 142
Download this page as JSON| Type | Event | Organ system | Group | Affected | At risk | Events |
|---|---|---|---|---|---|---|
| other | Anemia | Blood and lymphatic system disorders | Reltecimod (AB103) 0.5 mg/kg | 8 | 143 | 10 |
| other | Anemia | Blood and lymphatic system disorders | Placebo | 6 | 147 | 7 |
| other | Atrial fibrillation | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 7 | 143 | 7 |
| other | Atrial fibrillation | Cardiac disorders | Placebo | 8 | 147 | 8 |
| other | Diarrhea | Gastrointestinal disorders | Reltecimod (AB103) 0.5 mg/kg | 6 | 143 | 6 |
| other | Diarrhea | Gastrointestinal disorders | Placebo | 8 | 147 | 8 |
| other | Pneumonia | Infections and infestations | Reltecimod (AB103) 0.5 mg/kg | 5 | 143 | 5 |
| other | Pneumonia | Infections and infestations | Placebo | 11 | 147 | 11 |
| serious | Acute myocardial infarction | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 2 | 143 | 2 |
| serious | Acute myocardial infarction | Cardiac disorders | Placebo | 3 | 147 | 3 |
| serious | Atrial fibrillation | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 2 | 143 | 2 |
| serious | Atrial fibrillation | Cardiac disorders | Placebo | 3 | 147 | 3 |
| serious | Cardiac arrest | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 4 | 143 | 4 |
| serious | Cardiac arrest | Cardiac disorders | Placebo | 4 | 147 | 4 |
| serious | Cardio-respiratory arrest | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 1 | 143 | 1 |
| serious | Cardio-respiratory arrest | Cardiac disorders | Placebo | 0 | 147 | 0 |
| serious | Coronary artery perforation | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 1 | 143 | 1 |
| serious | Coronary artery perforation | Cardiac disorders | Placebo | 0 | 147 | 0 |
| serious | Pulmonary valve incompetence | Cardiac disorders | Reltecimod (AB103) 0.5 mg/kg | 0 | 143 | 0 |
| serious | Pulmonary valve incompetence | Cardiac disorders | Placebo | 1 | 147 | 1 |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02469857/events